Shay Barker - DrugBank Blog

Inside DrugBank

How keeping an eye on culture helped us grow sustainably

When it comes to growth we’re thinking long term, which to us means prioritizing the health and wellbeing of our team.

press releases

DrugBank recognized as one of Canada’s Best Workplaces™ by Great Place To Work®

We're happy to debut at #19 in the best places to work in Canada by the Great Place to Work Institute.

Announcements

What do you get when a compensation plan prioritizes a thriving life?

A Thriving Lifestyle Compensation Philosophy creates more than just a paycheque for our growing team.

A Year in Review: DrugBank’s 2020 Highlights

Happy New Year from our team here at DrugBank! When we authored our year in review at the end of 2019, we couldn’t have predicted what was to come for 2020. It’s been an incredibly challenging year for most folks around the globe with COVID-19 impacting the world’

press releases

DrugBank Announces Successful Fundraise, Plans to Scale Rapidly.

October 5, 2020 - FOR IMMEDIATE RELEASE. The DrugBank team is pleased to announce the completion of a successful investment round. Over the past year, DrugBank has focused its efforts to scale its business, setting ambitious goals for growth, and targeting opportunities to help them accomplish those goals. This included

FDA Approvals Monthly Roundup: August 2020

The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA approvals for August below. You can use the hot links to learn more about the drugs. Tafasitamab

FDA Approvals Monthly Roundup: July 2020

The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA approvals for July below. You can use the hot links to learn more about the drugs. FDA

Feature Announcements

Join us on Kaysen's Quest: Learn more about Gene Therapy, Zolgensma

As a company that specializes in drug information, DrugBank always tries to remain informed about novel treatments, drug approvals, and drugs that are impacting global health. At the top of our minds lately is Zolgensma [https://www.drugbank.ca/drugs/DB15528] (Onasemnogene abeparvovec), a gene therapy indicated for the treatment

Announcements

FDA Approvals Monthly Roundup: June 2020

The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA approvals for June below. You can use the hot links to learn more about the drugs. Artesunate

press releases

Edmonton Startup, DrugBank, Graduates from Creative Destruction Lab - West

May 27, 2020 - Edmonton based startup, DrugBank, recently graduated from the 2019/20 Creative Destruction Lab (CDL) Program. CDL is a seed-stage accelerator program for massively scalable, science-based companies. Its nine-month program pairs founders with experienced entrepreneurs and investors to set focused, measurable objectives with the goal of maximizing

COVID19

DrugBank joins as a supporter of Global Virtual Partnering Event to accelerate partnerships in the life sciences industry to fight COVID-19

PRESS CONTACT Shay Barker Operations Manager, DrugBank shay@drugbank.ca FOR IMMEDIATE RELEASE April 20, 2020 - DrugBank is pleased to announce they’ve joined a 3-day global virtual partnering event, organized by Inova, Lyonbiopole and Evaluate Ltd., and backed by a consortium of biotech clusters and leading trade associations

White Paper

UPDATED: COVID-19: Finding the Right Fit

With the global outbreak of COVID-19 spanning news stations and research labs across the world, the DrugBank team put their heads together to provide an overview of current data-driven approaches to identify potential COVID-19 therapies.

press releases

Edmonton Startup, DrugBank, Wins Inaugural Startup TNT $125,000 Investment

PRESS CONTACT Shay Barker Operations Manager, DrugBank shay@drugbank.ca FOR IMMEDIATE RELEASE February 21, 2020 - DrugBank, a local Edmonton technology startup, is the inaugural winner of the Startup TNT Investment Pitch Competition. The company will receive a $125,000 investment that will be used to grow their sales

FDA Approval Roundup - December 2019

Last month the FDA approved ten new drugs aimed at treating a broad spectrum of diseases and ailments. The FDA often approves a number of drugs over a short period of time before the new year, with the group of approvals being aptly called "December Drugs". Check out the approvals

The DrugBank team is headed to the Valley!

With the temperatures dropping substantially here in Alberta, the DrugBank team is excited to be headed to the sunshine in Santa Clara, California from January 21 - 24 for the Precision Medicine World Conference (PMWC). PMWC brings together over 2500 interdisciplinary professionals from the clinical healthcare space, academia, the pharmaceutical

Announcements

A Year in Review: DrugBank's 2019 Highlights

Happy New Year from our team here at DrugBank! 2019 was a wild year for us, and we wanted to share some of our top highlights with you: 1. We added 8 new team members to our growing company! We added roles in sales, operations, administration, curation, development, customer success,

press releases

Edmonton Startup DrugBank Pledges to Offset Company Travel Carbon Emissions

Co-Founders, Michael Wilson and Craig Knox, along with their team, have pledged to mitigate their travel emissions by purchasing carbon offsets for all business-related travel. With the help of Less Emissions [http://less.ca/], a Bullfrogpower Company, DrugBank can mitigate travel emissions quickly, effectively, and with the highest quality offsets

press releases

Edmonton Startup DrugBank accepted into Creative Destruction Lab - West 2019/20 Cohort

Edmonton based startup, DrugBank, has been accepted into the 2019/20 Creative Destruction Lab (CDL) program year. CDL is a seed-stage program for massively scalable, science-based companies. Its nine-month program pairs founders with experienced entrepreneurs and investors to set focused, measurable objectives with the goal of maximizing equity-value creation. Founded

Announcements

DrugBank is Crossing the Pond!

JOIN US AT THE 2019 AI IN DRUG DEVELOPMENT CONGRESS. We are hopping on a red-eye this week headed to London, UK, to take part in the 2019 AI in Drug Development Congress [https://www.oxfordglobal.co.uk/artificialintelligence-congress/]. We’re really excited to be participating in the Congress, and

Use Cases

Using DrugBank Data in AI Drug Discovery: A Case Study

High-quality data is the first step for training Machine-Learning (ML) and Artificial Intelligence (AI) algorithms, but obtaining this information is difficult as most knowledge about drugs exists within scientific publications in an unstructured text format. This is where DrugBank comes in.

Feature Announcements

DrugBank Fall 2019 Feature Release

The DrugBank team is proud to announce our Fall 2019 Feature Release. See the exciting updates below to learn about simple & clinical descriptions, supplemental ingredients, and more enhancements!

Announcements

DrugBank wins Prairie High-Growth Startup of the Year Award by Startup Canada

Startup Canada Press Release: DrugBank received the Startup Canada Prairie High-Growth Startup of the Year Award in Edmonton, presented by Mastercard Canada. As a proud sponsor of the sixth annual Startup Canada Awards, we are thrilled to recognize and celebrate outstanding achievement in Canada's entrepreneurship and innovation community across Canada.